StockData
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. (ENVB) stock

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.41−0.03 (-2.08%)

Close on Nov 17, 2026Market cap $6.31MP/E –Yield –

Enveric Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Enveric Biosciences's total debt was $1.00M at Mar 31, 2020. For fiscal 2019 it was $4.88M, down 6.4% from the year before. The highest annual figure on record is $6.68M in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$4.88M-6.4%
FY2018Dec 31, 2018$5.21M-22.0%
FY2017Dec 31, 2017$6.68M+32.9%
FY2016Dec 31, 2016$5.03M+307.0%
FY2015Dec 31, 2015$1.24M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2020Mar 31, 2020$1.00M-25.0%
Q4 FY2019Dec 31, 2019$4.88M+240.1%
Q4 FY2018Dec 31, 2018$5.21M-22.0%
Q3 FY2018Sep 30, 2018$7.69K-99.6%
Q2 FY2018Jun 30, 2018$1.33M-23.4%
Q1 FY2018Mar 31, 2018$1.44M+0.8%
Q4 FY2017Dec 31, 2017$6.68M+32.9%
Q3 FY2017Sep 30, 2017$1.98M–
Q2 FY2017Jun 30, 2017$1.74M–
Q1 FY2017Mar 31, 2017$1.42M–
Q4 FY2016Dec 31, 2016$5.03M–

More Enveric Biosciences figures

See a number that looks wrong?